Nuclear medicine imaging of infection in cancer patients (with emphasis on FDG-PET)

Oncologist

Volumn 16, Issue 7, 2011, Pages 980-991

  Bleeker Rovers, Chantal P ^a,b   Vos, Fidel J ^a,b,c   van der Graaf, Winette T A ^d   Oyen, Wim J G ^b  

^a Department of Internal Medicine   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SINT MAARTENSKLINIEK   (Netherlands)

^d Department of Medical Oncology ^*  (Netherlands)

Author keywords

Cancer; FDG PET; Infection; Neutropenia; Scintigraphy

Indexed keywords

ANTIBIOTIC AGENT; ETIDRONIC ACID TC 99M; FLUORODEOXYGLUCOSE; GALLIUM 67; GALLIUM 68; GALLIUM CITRATE GA 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; MEDRONATE TECHNETIUM TC 99M; TECHNETIUM 99M;

ARTICLE; BACTEREMIA; BLOOD VESSEL GRAFT; BRAIN LYMPHOMA; CANCER PATIENT; CELL LABELING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEBRILE NEUTROPENIA; GRAFT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; JOINT PROSTHESIS; KAPOSI SARCOMA; LEUKOCYTE; MALIGNANT NEOPLASTIC DISEASE; METAL IMPLANTATION; METASTASIS POTENTIAL; NEUTROPENIA; NONHUMAN; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; PROSTHESIS INFECTION; SENSITIVITY AND SPECIFICITY; THROMBOPHLEBITIS;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFECTION; MALE; MIDDLE AGED; NEOPLASMS; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; YOUNG ADULT;

EID: 79960879470     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0421     Document Type: Article

References (49)

1. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med 1994;24:128-141.
2. Bartold SP, Donohoe KJ, Fletcher JW, et-alet al/et-al. Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine. J Nucl Med 1997;38:990-994.
3. Perkins PJ. Early gallium-67 abdominal imaging: Pitfalls due to bowel activity. AJR Am J Roentgenol 1981;136:1016-1017.
4. Bekerman C, Hoffer PB, Bitran JD. The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 1984;14:296-323.
5. Nanni C, Errani C, Boriani L, et al. Ga-citrate PET/CT for evaluating patients with infections of the bone: Preliminary results. J Nucl Med 2010;51: 1932-1936.
6. Peters AM. The utility of [99mTc]HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994;24:110-127.
7. Datz FL, Thorne DA. Effect of chronicity of infection on the sensitivity of the In-111-labeled leukocyte scan. AJR Am J Roentgenol 1986;147:809-812.
8. Weissman AF, Dayanikli F, Schlesinger AE et al. Indium-111 leukocyte uptake in a patient with osseous metastatic Ewing's sarcoma. Clin Nucl Med 1993;18:1063-1066.
9. Staudinger KM, Oates E, Naber SP. In-111 labeled leukocyte uptake in metastatic melanoma. Clin Nucl Med 1989;14:626.
10. Becker W, Schaffer R, Börner W. Sigmoid carcinoma mimicking an intra-abdominal abscess in an 111In-labeled white blood cell scan. Eur J Nucl Med 1985;11:283-284.
11. Schell-Frederick E, Fruhling J, van der Auwera P, et al. Indium-oxine-labeled leukocytes in the diagnosis of localized infection in patients with neoplastic disease. Cancer 1984;54:817-824.
12. Fortner A, Datz FL, Taylor A, et al. Uptake of In-labeled leukocytes by tumor. AJR Am J Roentgenol 1986;146:621-625.
13. Schmidt KG, Rasmussen JW, Wedebye IM et al. Accumulation of indium-111-labeled granulocytes in malignant tumors. J Nucl Med 1988;29:479- 484.
14. Lamki LM, Kasi LP, Haynie TP. Localization of indium-111 leukocytes in noninfected neoplasms. J Nucl Med 1988;29:1921-1926.
15. AL-Nahhas AM, Hjiyiannakis P, Hammersley PA et al. Uptake of techne-tium-99m hexamethylpropylene amine oxime labelled white cells inlymph nodes involved in non-Hodgkin's lymphoma. Eur J Nucl Med 1995;22: 1453-1456.
16. Lantto E, Järvi K, Lantto T et al. Accumulation of leucocytes labelled with technetium-99m hexamethylpropylene amine oxime in malignant abdominal tumours. Eur J Nucl Med 1991;18:824-828.
17. Yamada S, Kubota K, Kubota R et al. High accumulation of fluorine-18-fluorodeoxyglucose inturpentine-induced inflammatory tissue.JNucl Med 1995;36:1301-1306.
18. Sugawara Y, Gutowski TD, Fisher SJ et al. Uptake of positron emission tomography tracers in experimental bacterial infections: A comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, Ga-citrate, and I-HSA. Eur J Nucl Med 1999;26:333-341.
19. De Winter F, Vogelaers D, Gemmel F et al. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 2002;21:247-257.
20. de Groot M, Meeuwis AP, Kok PJ et al. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005;32:98-101.
21. Rosenbaum SJ, Lind T, Antoch G et al. False-positive FDG PET uptake- the role of PET/CT. Eur Radiol 2006;16:1054-1065.
22. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006;82:1016-1020.
23. Sahlmann CO, Siefker U, Lehmann K et al. Dual time point 2-[18F]fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis. Nucl Med Commun 2004;25:819-823.
24. Gaytàn-Martínez J, Mateos-GarcíaE, Sanchez-Cortés Eetal. Microbiological findings in febrile neutropenia. Arch Med Res 2000;31:388-392.
25. Roongpoovapatr P, Suankratay C. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2010;93:776-783.
26. Paul M, Yahav D, Fraser A et al. Empirical antibiotic monotherapy for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2006;57:176-189.
27. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Se-min Nucl Med 2002;32:47-59.
28. Ho AY, Pagliuca A, Maisey MN et al. Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections. Br J Haematol 1998;101:392-393.
29. Mahfouz T, Miceli MH, Saghafifar F, et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: A study of 165 infectious episodes. J Clin Oncol 2005;23:7857-7863.
30. Kubota R, Yamada S, Kubota K et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33: 1972-1980.
31. Brown RS, Leung JY, Fisher SJ et al. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995;36:1854-1861.
32. Brewer S, McPherson M, Fujiwara D et al. Molecular imaging of murine intestinal inflammation with 2-deoxy-2-[18F]fluoro-D-glucose and positron emission tomography. Gastroenterology 2008;135:744-755.
33. Meller J, Sahlmann CO, Lehmann K, et al. [F-18-FDG hybrid camera PET in patients with postoperative fever]. Nuklearmedizin 2002;41:22-29.
34. van der Bruggen W, Bleeker-Rovers CP, Boerman OC et al. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: A systematic review. Semin Nucl Med 2010;40:3-15.
35. Zhuang H, Chacko TK, Hickeson M et al. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur J Nucl Med Mol Imaging 2002;29:1328-1333.
36. Chacko TK, Zhuang H, Nakhoda KZ et al. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 2003;24:615-624.
37. de Winter F, van de Wiele C, Vogelaers D et al. Fluorine-18 fluorodeoxy-glucose-position emission tomography: A highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001;83:651-660.
38. Schiesser M, Stumpe KD, Trentz O et al. Detection of metallic implant-associated infections with FDG PET in patients with trauma: Correlation with microbiologic results. Radiology 2003;226:391-398.
39. Bleeker-Rovers CP, Vos FJ, Wanten GJ et al. F-FDG PET in detecting metastatic infectious disease. J Nucl Med 2005;46:2014-2019.
40. Vos FJ, Bleeker-Rovers CP, Sturm PD et al. F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med 2010;51: 1234-1240.
41. Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging 2009;53:35-40.
42. Fukuchi K, Ishida Y, Higashi M et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: Comparison with computed tomographic findings. J Vasc Surg 2005;42:919-925.
43. Keidar Z, Engel A, Hoffman A, et al. Prosthetic vascular graft infection: The role of 18F-FDG PET/CT. J Nucl Med 2007;48:1230-1236.
44. Spacek M, Belohlavek O, Votrubova J et al. Diagnostics of "non-acute" vascular prosthesis infection using F-FDG PET/CT: Our experience with 96 prostheses. Eur J Nucl Med Mol Imaging 2009;36:850-858.
45. Gardet E, Addas R, Monteil J et al. Comparison of detection of F-18 fluo-rodeoxyglucose positron emission tomography and 99mTc-hexamethyl-propylene amine oxime labelled leukocyte scintigraphy for an aortic graft infection. Interact Cardiovasc Thorac Surg 2010;10:142-143.
46. O'Doherty MJ, Barrington SF, Campbell M et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997;38:1575-1583.
47. Castaigne C, Tondeur M, de Wit S et al. Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: A retrospective study. Nucl Med Commun 2009;30:41-47.
48. Sathekge M, Maes A, Kgomo M et al. FDG uptake in lymph-nodes of HIV+ and tuberculosis patients: Implications for cancer staging. Q J Nucl Med Mol Imaging 2010;54:698-703.
49. van de Luijtgaarden A, van der Ven A, Leenders W et al. Imaging of HIV-associated Kaposi sarcoma; F-18-FDG-PET/CT and In-111-bevacizumab scintigraphy. J Acquir Immune Defic Syndr 2010;54:444-446.